Title: Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: Multistage hepatocarcinogenesis with multifactorial etiology
Abstract: HepatologyVolume 36, Issue 5 p. 1046-1049 EditorialsFree Access Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: Multistage hepatocarcinogenesis with multifactorial etiology Chien-Jen Chen Sc.D., Corresponding Author Chien-Jen Chen Sc.D. [email protected] Graduate Institute of Epidemiology, College of Public Health, Taipei, TaiwanGraduate Institute of Epidemiology, College of Public Health, 1 Jen-Ai Road Section1 Room 1547, Taipei 10018, Taiwan. fax: (886) 2-2378-3833.===Search for more papers by this authorDing-Shinn Chen M.D., Ding-Shinn Chen M.D. From the Department of Internal Medicine, College of Medicine, Taipei, TaiwanSearch for more papers by this author Chien-Jen Chen Sc.D., Corresponding Author Chien-Jen Chen Sc.D. [email protected] Graduate Institute of Epidemiology, College of Public Health, Taipei, TaiwanGraduate Institute of Epidemiology, College of Public Health, 1 Jen-Ai Road Section1 Room 1547, Taipei 10018, Taiwan. fax: (886) 2-2378-3833.===Search for more papers by this authorDing-Shinn Chen M.D., Ding-Shinn Chen M.D. From the Department of Internal Medicine, College of Medicine, Taipei, TaiwanSearch for more papers by this author First published: 30 December 2003 https://doi.org/10.1053/jhep.2002.37084Citations: 93AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 DM Parkin, SL Whelan, J Ferlay, L Raymond, J Young, eds. Cancer Incidence in Five Continents. Vol. VII. IARC Scientific Publication No. 143. Lyon, France: IARC, 1997: 832– 833. 2 Chen CJ, Yu MW, Liaw YF. Epidemiology and multifactorial etiology of hepatocellular carcinoma. J Gastroenterol Hepatol 1997; 12: S294– S308.MEDLINE 3 Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, Beasley P, et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002; 36: 1206– 1213. 4 Ming L, Thorgeirisson SS, Gail MH, Lu P, Harris CC, Wang N, Shao Y, et al. Dominant role of hepatitis B virus and co-factor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology 2002; 36: 1214– 1220. 5 Beasley RP. Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer 1985; 61: 1942– 1956. 6 Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao K, et al. Hepatitis B e antigens and the risk of hepatocellular carcinoma. N Engl J Med 2002; 347: 168– 174.MEDLINE 7 Yeh SH, Chen PJ, Shau WY, Chen YW, Lee PH, Chen JT, Chen DS. Chromosomal allelic imbalance evolving from cirrhosis to hepatocellular carcinoma. Gastroenterology 2001; 121: 699– 709.MEDLINE 8 Yu MW, Hsu FC, Sheen IS, Chu CM, Lin DY, Chen CJ, Liaw YF. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 1997; 145: 1039– 1047.MEDLINE 9 Wang LY, Chen CJ, Zhang YJ, Tsai WY, Lee PH, Lee CS, Santella RM. 4-aminobipheyl-DNA damage in liver tissue of hepatocellular carcinoma patients and controls. Am J Epidemiol 1998; 147: 315– 323.MEDLINE 10 Chen SY, Wang LY, Lunn RM, Tsai WY, Lee PH, Lee CS, Ahsan H, et al. Polycyclic aromatic hydrocarbons-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls. Int J Cancer 2002 (in press). 11 Wang LY, Hatch M, Chen CJ, Levin B, You SL, Lu SN, Wu MH, et al. Aflatoxin exposure and the risk of hepatocellular carcinoma in Taiwan. Int J Cancer 1996; 67: 620– 625.MEDLINE 12 Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinoma. Nature 1991; 350: 427– 428.MEDLINE 13 Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855– 4878.MEDLINE 14 Yu MW, Chen CJ. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol 1994; 17: 71– 91.MEDLINE 15 Chen CJ, Liang KY, Chang AS, Chang YC, Lu SN, Liaw YF, Chang WY, et al. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 1991; 13: 398– 406.MEDLINE 16 Chen CJ, Yu MW, Liaw YF, Wang LW, Chiamprasert S, Matin F, Hirvonen A, et al. Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxins are at increased risk of hepatocellular carcinoma. Am J Hum Genet 1996; 59: 128– 134.MEDLINE 17 Yu MW, Chiu YH, Yang SY, Santella RM, Chern HD, Liaw YF, Chen CJ. Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers. Br J Cancer 1999; 80: 598– 603.MEDLINE 18 Yu MW, Gladek-Yarborough A, Chiamprasert S, Santella RM, Liaw YF, Chen CJ. Cytochrome P-450 2E1 and glutathione S-transferase GSTM1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology 1995; 109: 1266– 1273.MEDLINE 19 Yu MW, Pai CI, Yang SY, Hsiao TJ, Chang HC, Lin SM, Liaw YF, et al. Role of N-acetyltransferase polymorphisms in hepatitis B-related hepatocellular carcinoma: impact on risk of smoking. Gut 2000; 47: 703– 709.MEDLINE 20 Chang MH, Chen CJ, Lai MS, Kong MS, Wu TC, Liang DC, Hsu HM, et al for the Taiwan Childhood Hepatoma Study Group. Nationwide hepatitis B vaccination and the incidence of hepatocellular carcinoma in children in Taiwan. N Engl J Med 1997; 336: 1855– 1859.MEDLINE Citing Literature Volume36, Issue5November 2002Pages 1046-1049 ReferencesRelatedInformation